33311-29-4

Basic information

• Product Name: 4-(2-METHOXYETHOXY)ANILINE
• Synonyms: 4-(2-methoxyethoxy)aniline(SALTDATA: HCl);4-(2-Methoxyethoxy)-benzenaMine;p-Phenetidine, β-methoxy-;4-(2-Methoxyethoxy);AKOS BC-2489;AKOS BBB/095;4-(2-METHOXYETHOXY)ANILINE;ASISCHEM C40525
• CAS NO: 33311-29-4
• Molecular Formula: C₉H₁₃NO₂
• Molecular Weight: 167.20502
• Mol File: 33311-29-4.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 294.3°C at 760 mmHg
• Flash Point: 143.5°C
• Appearance: /
• Density: 1.078g/cm³
• Vapor Pressure: 0.00163mmHg at 25°C
• Refractive Index: 1.533
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 5.10±0.10(Predicted)
• CAS DataBase Reference: 4-(2-METHOXYETHOXY)ANILINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-METHOXYETHOXY)ANILINE(33311-29-4)
• EPA Substance Registry System: 4-(2-METHOXYETHOXY)ANILINE(33311-29-4)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 33311-29-4(Hazardous Substances Data)

Usage

General Description

4-(2-Methoxyethoxy)aniline is a chemical compound with the molecular formula C9H13NO2. It is a pale yellow to brown liquid at room temperature and is commonly used in industrial applications as a solvent, intermediate, or additive. It is also known by the trade names Dimethoxyethylphenylamine and DMEP. 4-(2-METHOXYETHOXY)ANILINE is often utilized in the production of dyes, pharmaceuticals, and other organic compounds. It has a variety of functional groups that make it useful for a range of chemical reactions, and it is important for researchers and chemists to understand its properties and applications in order to utilize it effectively and safely.

InChI:InChI=1/C9H13NO2/c1-11-6-7-12-9-4-2-8(10)3-5-9/h2-5H,6-7,10H2,1H3

Upstream product

• 109-86-4 2-methoxy-ethanol 
• 540-37-4 p-aminoiodobenzene 
• 350-46-9 4-Fluoronitrobenzene 
• 100-02-7 4-nitro-phenol 
• 22483-40-5 4-(2-methoxy-ethoxy)-1-nitrobenzene 
• 110969-99-8 acetic acid-[4-(2-methoxy-ethoxy)-anilide] 

Downstream Products

• 1202760-31-3 C₂₄H₂₈BrN₅O₄ 
• 1616380-94-9 tert-butyl (5-fluoro-2-((4-(2-methoxyethoxyl)phenyl)amino)pyrimidin-4-yl)(3-(N-hydroxyacrylamido)phenyl)carbamate 
• 1616380-79-0 N₄-(2-(benzyloxy)-5-nitrophenyl)-5-fluoro-N₂-(4-(2-methoxyethoxyl)phenyl)pyrimidine-2,4-diamine 
• 50982-75-7 4-(2-methoxy-ethoxy)-2-nitro-phenylamine 

Relevant articles and documents

S-triazine compounds as well as preparation method and application thereof

The invention discloses s-triazine compounds and pharmaceutically acceptable salts thereof; experiments prove that the compounds can be used for treating or preventing diseases related to protein kinase activity, such as leukemia and lymphoma, by inhibiti

As tyrosine kinase inhibitors containing nitrogen and ring compound

The invention belongs to the technical field of medicine, particularly relates to a heterocyclic nitrogen compound which acts as a tyrosine kinase inhibitor and is represented by a general formula (I) as well as a deuterated material, pharmaceutically acc

Eeyarestatin I derivatives with improved aqueous solubility

Inhibition of p97 (also known as valosin-containing protein (VCP)), has been validated as a promising strategy for cancer therapy. Eeyarestatin I (EerI) blocks p97 through a novel mechanism of action and has favorable anti-cancer activities against cultured cancer cells. However, its poor aqueous solubility severely limits its in vivo applications. To circumvent this problem, we have identified EerI derivatives that possess improved aqueous solubility by introducing a single solubilizing group. These modified compounds preserved endoplasmic reticulum (ER) stress-inducing and antiproliferative activities as well as generally good in vitro metabolic properties, suggesting that these EerI derivatives could serve as candidates for further optimization.